Product status tracker
Separate approval, development and catalog status.
Product names can appear in trials, FDA records, compounding reviews and research catalogs without carrying the same regulatory meaning. Each tracker states the entity, source date and decision boundary.
Verified status records
Read the current record—not a copied status claim.
Read the methods, limitations and original sources behind each guide.
AOD-9604 Development and Compounding Status
FDA’s December 2024 evaluation proposed not adding AOD-9604 free base or acetate to the 503A Bulks List, citing characterization, effectiveness and safety limitations. That compounding-list evaluation is not a product approval review and should not be rewritten as one.
Open verified status →BPC-157 Regulatory and Evidence Status
FDA’s July 2026 advisory materials evaluated BPC-157-related bulk substances for possible inclusion on the 503A Bulks List and proposed that BPC-157 free base and acetate not be included. Advisory recommendations are non-binding; this page does not claim a final rule that the cited record does not establish.
Open verified status →CJC-1295 and CJC-1295 DAC Regulatory Status
FDA’s December 2024 compounding review proposed that multiple CJC-1295 and CJC-1295 DAC forms not be included on the 503A Bulks List. The naming distinction between DAC and non-DAC materials remains material to identity and evidence interpretation.
Open verified status →Retatrutide Development and Approval Status
Lilly identifies retatrutide as an investigational triple agonist and states that it is not currently approved by FDA. Phase 3 topline announcements do not constitute marketing approval or a complete peer-reviewed evidence package.
Open verified status →Tirzepatide: Approved Finished Medicines vs Research Material
FDA labeling identifies tirzepatide as the active ingredient in approved finished medicines including Zepbound. Approval applies to the named drug products, presentations, manufacturing controls and labeled conditions—not to every material sold under the ingredient name.
Open verified status →How to use this center
Start with the decision, then choose the record.
Use the analytical center when a test result, specification or certificate needs interpretation. Use the status tracker when a product name is being connected to an approval, development program or compounding action.
Defines catalog identity, variants and lot-document scope.
Explains what a measurement can support and where it stops.
Groups source records without mixing human, animal and analytical evidence.
Separates regulatory entities and preserves dated source language.
Continue the review